Great writing as always Rudi. I'm one in the "I wish I never sold part of my shares" bracket, but have still done very well over the long-term with CSL. So much credit must got to Brian McNamee and his time as CEO. So far it's looking like business as usual under Paul Perrault term.
So today we just close our eyes and " Buy and Hold " if we waited too long because it was considered too expensive previously ?
Very good article, again, Rudi - many thanks. I own it, and am likely to buy more. It's a company where you just get a strong feeling that the board can be trusted, all of the time, to make good, solid, decisions.
Thank you Rudi for a great article on CSL. I have owned shares since 2006 and they represent a fantastic return. A company is only as good as its board and CEO . CSL I believe is in very good hands.
Excellent article, never disappointed by your analysis
I'm no expert on plasma, but are CSL's advantages open to technological changes? eg in ten years time, there is a way to make plasma in a lab rather than collect it?
Good article. In defense of technical analysis I'm not sure how you decided technical analysts thought it was going to $100. People who look at charts aren't a homogeneous group. I use monthly charts. My monthly chart said the last buy signal occured in 2017 and there have been no sell signals since then. Prior to that a buy signal occured in 2012 and a sell signal in late 2016. In the first case I have increased my capital, to date, 250% and in the second case it increased 360%.